BackBarinthus Biotherapeutics Plc. Overview

Barinthus Biotherapeutics Plc. Intangible Assets

Latest intangible assets for BRNS: $14M.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$13.67M
↓ 35.40% YoYΔ $-7.49M vs prior year quarter

Peer average

Loading

Barinthus Biotherapeutics Plc. Intangible Assets History

Loading

Barinthus Biotherapeutics Plc. vs. peers: Intangible Assets Comparison

Loading

Barinthus Biotherapeutics Plc. Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Barinthus Biotherapeutics Plc. (BRNS) FAQ

As of the most recent data (March 2026), BRNS shows a intangible assets of $14M. That compares with $21M in the prior-year period — down 35.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BRNS's intangible assets is now $14M (was $21M) — a 35.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Barinthus Biotherapeutics Plc. is outperforming or lagging.

Tracking BRNS's intangible assets over time shows whether Barinthus Biotherapeutics Plc. is scaling, shrinking, or reshaping that part of the business. The current reading is $14M That compares with $21M in the prior-year period — down 35.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Barinthus Biotherapeutics Plc.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $14M) with ownership activity and broader fundamentals.

Barinthus Biotherapeutics Plc.'s intangible assets is $14M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.